CLINICAL_TRIALS
trial_result
· 2014-12-03
Clinical Trial Update: Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DM [Phase 3]
Summary
Phase 3 trial update evaluating the ease of use and safety of the U300 insulin pen injector in insulin-naïve adults with Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED